Unexplained pneumonia cases caused by a new coronavirus known as SARS-COV-2, occurred in Wuhan, China since December 2019. Culprit of the worldwide pandemic of the coronavirus disease 2019 (COVID-19), SARS-CoV-2 attach to the angiotensin-converting enzyme 2 receptor, affecting multiple systems such as respiratory, vascular, renal and central nervous system. Most common neurological symptoms are headache, dizziness, nausea, vomiting, myalgia, anosmia, ageusia and altered consciousness; however, there are reports that suggests an association between Guillain-Barre syndrome (GBS) and COVID-19 infection. Guillain-Barre syndrome (GBS) is an autoimmune polyradiculoneuropathy that characterized with progressive weakness of the limbs and reduction or loss of tendon reflexes. Protein concentrations of cerebrospinal fluid (CSF) are increased and the white cell count is normal. Plasma exchange and intravenous immunoglobulin (IVIG) used in treatment with supportive care and most of patients have full recovery. In this paper we aimed to present a patient with positive real time polymerase chain reaction (RT-PCR) test presenting to the emergency department (ED) with the symptoms of GBS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.